Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cleerly logo — Personalized precision heart health

Cleerly

Personalized precision heart health

Founded 2017 United States Denver, United States 195 employees Series C Total: $386.48M AI, Health Care +1

General Information

Company Name Cleerly
Founded Year 2017
Location United States Denver, United States
Founders / Decision Makers
Team member Team member
Employees 195
Industries AI, Health Care, Health and Wellness
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Cleerly. To contact Cleerly, visit cleerlyhealth.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cleerly

Cleerly, with the slogan "Personalized precision heart health," is a Health Care startup founded in 2017, headquartered in the United States. The company is dedicated to eliminating heart attacks by establishing a new standard of care for diagnosing heart disease. Cleerly leverages AI-empowered solutions to support comprehensive phenotyping of coronary artery disease through the evaluation of advanced non-invasive CT imaging. Their approach is built on almost 20 years of science from landmark multi-center clinical trials, aiming to enhance health literacy for all stakeholders in the coronary care pathway. The most recent milestone for Cleerly was a $223.00M Series C investment on 25 July 2022. This investment was led by a syndicate of prominent investors including Novartis, T. Rowe Price, Catalytic Impact Foundation, Cigna Ventures, DigiTx Partners, LRV Health, Mirae Asset Capital, Presight Capital, Vensana Capital, and Peter Thiel. This substantial investment is a testament to the confidence that industry leaders have in Cleerly's mission and the potential of its AI-driven approach to revolutionize heart health care. With the support of these investors, Cleerly is well-positioned to continue its groundbreaking work towards preventing heart attacks and improving cardiovascular health outcomes.

Taxonomy: Cardiology, Digital Healthcare, Personalized Health, Heart Disease, Cardiovascular AI Software

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $106.00M 2
Battery Ventures Insight Partners
Battery Ventures, Insight Partners
05 Dec 2024
Series C $223.00M 10
Novartis T. Rowe Price Catalytic Impact Foundation
Novartis, T. Rowe Price +8
25 Jul 2022
Series B $43.00M -
21 Jun 2021
Series A $14.48M -
10 Aug 2017

Latest News

View All
Kalp hastalıklarının erken teşhisine odaklanan Cleerly, 106 milyon dolar yatırım aldı — Webrazzi
Kalp hastalıklarının erken teşhisine odaklanan Cleerly, 106 milyon dolar yatırım aldı
Webrazzi Dec 05, 2024

Cleerly Alternatives & Competitors

View All Alternatives
Cleerly vs
ScriptChain Health
ScriptChain Health United States

Making a positive impact in the world, starting with your heart.

Pre-Seed
9 employees
AI, Health Care
Cleerly vs
Eko Health
Eko Health United States

Eko is a leading digital health company advancing how healthcare professionals detect and monitor he...

Series D
201 employees
AI, Digital Health
Cleerly vs
Hello Heart
Hello Heart United States

Empowering people to understand and improve their heart health using technology and behavioral scien...

Series D
617 employees
Digital Health, Health Care
View all alternatives

FAQ About Cleerly

Personalized precision heart health
Cleerly was founded in 2017.
Cleerly is headquartered in Denver, United States.
Cleerly operates in AI, Health Care and Health and Wellness. Its work centres on Cardiology, Digital Healthcare, Personalized Health and Heart Disease.
Cleerly has approximately 195 employees.
Cleerly has completed 4 funding rounds, raising a total of $386.48M. The latest funding stage is Series C.
Top alternatives and competitors to Cleerly include ScriptChain Health, Eko Health, Hello Heart, Cardisio, Mediwhale. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cleerly and ScriptChain Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cleerly, https://bouncewatch.com/company/cleerly, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes